Dose Response Study of Patients With Erythematous Rosacea

NCT01186068 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythematous (Type One) Rosacea

Interventions

DRUG: V-101
OTHER: vehicle

Sponsor

Vicept Therapeutics, Inc.

Collaborators

[object Object]